...in sequence data available, scientists are increas... of information that determines a protein,s functi...proteins differ, such information can also help sc...cientists at the U.S. Department of Energy,s Brook...program "to sort the informational ,wheat, from th...
...es plays a role in how our arms and legs develop a... bits of material once dismissed as genetic "junk,...Harvard University. , The research, available toda...ists understand whether bits of RNA called microRN...ment not just by strategically turning off gene ac...
...ationwide will today for the first time be able to...ch for genes that underlie a range of chronic dise...t and other common diseases have been providing bl... of a project hosted by The University of Manchest...re to study genes in chronic diseases. The project...
Other Biology News:Scientists develop protein-sequence analysis tool 2MicroRNA may have fail-safe role in limb development 2'Dating agency' boosts hunt for disease genes 2(Date:11/24/2009)...ONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Th...nc., a leading provider of advanced laser systems ...tility clinic markets, today reported operational ...September 30, 2009. , , Q3 2009 Highlights, ...3 million in Q3 2008, - Gross profit margin w...
(Date:11/24/2009)... Arena Pharmaceuticals, ...ompany is scheduled to present at the Piper Jaffra..., 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pacif...City. Jack Lief, Arena,s President and Chief Execu...of the company, including its clinical development...
(Date:11/24/2009)...e/--HealthRoboticstodayannounced,thatithasformedan...rs.ThisrecentlyformedToronto-basedcompanywillopera...ket,install,andsupport,HealthRobotics,i.v.Roomofth...ctofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM)...eonan"asneeded,basis"toitsstrategicpartnershipswit...
(Date:11/24/2009)...acts Service (CAS), the global expert on chemical ... now the world,s leading producer of patent invent...,s patent office, the World Intellectual Property ...and Trademark Office (USPTO) for more than a decad... exceeded Japan for the first time on a monthly ba...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3...ent Results in Improvements in Physical ...AN FRANCISCO, Oct. 27 More than half of patients,...of golimumab (CNTO 148),50 mg and 100 mg, an inves...ents in the joint and skin symptoms of active psor...stained through one year.,Golimumab-treated patien...
...apeutics,(Nasdaq: FOLD ) will announce third quar... of markets on Monday, November 3, 2008. The resul...nce call and webcast that,afternoon at 5 p.m. ET.,... the conference call at,5 p.m. ET by dialing 877-4...al). A telephonic replay of the call will be avail...
...FirstCall/ -- China Medical,Technologies, Inc. (th...ed,medical device company that develops, manufactu...ucts today announced that it will report selected,... revenues, net income and,earnings per ADS for the...2Q FY2008") on November 18, 2008 and full unaudite...
Other Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 3... inL10 Workstation from Caliper represents a revol...y, offering for the first time the ability to gene...ly react to changing conditions. In addition, eac... viscosity due to changes in temperature, and offe...
... Series of systems provide fast and reliable scala...s, proteomics and drug development laboratories. S...urations; Mini Workstation Series, Application Ser...cation Series systems use a revolutionary new base...
...over 20 years of experience in providing versatile...the Freedom EVO platform delivers even more flexib... future needs. Together with the new easy-to-use s...to successfully operate genomics, proteomics, and ...
...n Filter is a novel disposable spin filtration dev...f bacterial lysates in plasmid purification proced...disposable spin filtration device especially desig...in plasmid purification procedures. The neutralize...
Biology Products: